Risk of bleeding not increased by sorafenib or sunitinib - Authors' reply

Youjin Je, Fabio AB Schutz, Toni K. Choueiri

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Access to Document

@article{926b5673feb8421bb21ada83b985729c,

title = "Risk of bleeding not increased by sorafenib or sunitinib - Authors' reply",

author = "Youjin Je and Schutz, {Fabio AB} and Choueiri, {Toni K.}",

year = "2010",

month = feb,

doi = "10.1016/S1470-2045(10)70016-4",

language = "English",

volume = "11",

pages = "113",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Risk of bleeding not increased by sorafenib or sunitinib - Authors' reply

AU - Je, Youjin

AU - Schutz, Fabio AB

AU - Choueiri, Toni K.

PY - 2010/2

Y1 - 2010/2

UR - http://www.scopus.com/inward/record.url?scp=75249094055&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(10)70016-4

DO - 10.1016/S1470-2045(10)70016-4

M3 - Letter

AN - SCOPUS:75249094055

SN - 1470-2045

VL - 11

SP - 113

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -